Gilead Sciences
Patents, Design & Utilities
Last updated:
List of all Gilead Sciences patents 302 in total
| Status | Patent |
|---|---|
Application | Utility: METHODS FOR TREATING FILOVIRIDAE VIRUS INFECTIONS Filling date: 6 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE Filling date: 6 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: PROCESSES FOR PREPARING ACC INHIBITORS AND SOLID FORMS THEREOF Filling date: 6 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: PD-1/PD-L1 INHIBITORS Filling date: 6 Sep 2025 Issue date: 28 Jan 2021 |
Grant | Utility: PD-1/PD-L1 inhibitors Filling date: 6 Sep 2025 Issue date: 26 Jan 2021 |
Application | Utility: HIV VACCINES AND METHODS OF MAKING AND USING Filling date: 6 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: PROCESSES FOR PREPARING TOLL-LIKE RECEPTOR MODULATOR COMPOUNDS Filling date: 6 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE Filling date: 6 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: METHODS OF TREATING LIVER DISEASE Filling date: 6 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: FLT3L-Fc FUSION PROTEINS AND METHODS OF USE Filling date: 6 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: THERAPEUTIC COMPOUNDS Filling date: 6 Sep 2025 Issue date: 14 Jan 2021 |
Grant | Utility: Human immunodeficiency virus neutralizing antibodies Filling date: 6 Sep 2025 Issue date: 5 Jan 2021 |
Grant | Utility: Multispecific antibodies that target HIV GP120 and CD3 Filling date: 6 Sep 2025 Issue date: 5 Jan 2021 |
Grant | Utility: 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections Filling date: 6 Sep 2025 Issue date: 5 Jan 2021 |
Grant | Utility: Pyrrolo[1,2-B]pyridazine derivatives Filling date: 6 Sep 2025 Issue date: 29 Dec 2020 |
Grant | Utility: Substituted pyrrolizine compounds and uses thereof Filling date: 6 Sep 2025 Issue date: 29 Dec 2020 |
Application | Utility: Choline Salt Forms of an HIV Capsid Inhibitor Filling date: 6 Sep 2025 Issue date: 24 Dec 2020 |
Grant | Utility: Antibodies and fragments thereof that bind hepatitis B virus protein X Filling date: 6 Sep 2025 Issue date: 22 Dec 2020 |
Application | Utility: COT MODULATORS AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: SUBSTITUTED ENEOXINDOLES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: CRYSTALLINE FORMS OF (2R,5S,13AR)-8-HYDROXY-7,9-DIOXO-N-(2,4,6-TRIFLUOROBENZYL)-2,3,4,5,7,9,13- ,13A-OCTAHYDRO-2,5-METHANOPYRIDO[1',2':4,5]PYRAZINO[2,1-B][1,3]OXAZEPINE-1- 0-CARBOXAMIDE Filling date: 6 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: MULTISPECIFIC ANTIBODIES THAT TARGET HIV GP120 AND CD3 Filling date: 6 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: METHODS OF TREATING FELINE CORONAVIRUS INFECTIONS Filling date: 6 Sep 2025 Issue date: 3 Dec 2020 |
Grant | Utility: Choline salt forms of an HIV capsid inhibitor Filling date: 6 Sep 2025 Issue date: 1 Dec 2020 |
Grant | Utility: Crystalline forms of ethyl ((S)-((((2R,5R)-5-(6-amino-9H-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)- oxy)methyl)(phenoxy)phosphoryl(-L-alaninate Filling date: 6 Sep 2025 Issue date: 1 Dec 2020 |
Application | Utility: FXR (NR1H4) MODULATING COMPOUNDS Filling date: 6 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: METHODS OF IDENTIFYING HIV PATIENTS SENSITIVE TO THERAPY WITH GP120 V3 GLYCAN-DIRECTED ANTIBODIES Filling date: 6 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS Filling date: 6 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: COMPOSITIONS COMPRISING AN RNA POLYMERASE INHIBITOR AND CYCLODEXTRIN FOR TREATING VIRAL INFECTIONS Filling date: 6 Sep 2025 Issue date: 19 Nov 2020 |
Application | Utility: Quinazoline Compounds Filling date: 6 Sep 2025 Issue date: 19 Nov 2020 |
Grant | Utility: Substituted pyrrolizine compounds and uses thereof Filling date: 6 Sep 2025 Issue date: 17 Nov 2020 |
Grant | Utility: Therapeutic compounds Filling date: 6 Sep 2025 Issue date: 17 Nov 2020 |
Grant | Utility: Crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5- (4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(p- henoxy) phosphoryl)amino)propanoate Filling date: 6 Sep 2025 Issue date: 17 Nov 2020 |
Application | Utility: METHODS FOR TREATING ARENAVIRIDAE AND CORONAVIRIDAE VIRUS INFECTIONS Filling date: 6 Sep 2025 Issue date: 12 Nov 2020 |
Grant | Utility: Crystalline monomesylate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidaz- o[1,2-a]pyrazin-8-amine Filling date: 6 Sep 2025 Issue date: 10 Nov 2020 |
Application | Utility: SOLID FORMS OF A TOLL-LIKE RECEPTOR MODULATOR Filling date: 6 Sep 2025 Issue date: 5 Nov 2020 |
Application | Utility: SOLID FORMS OF AN HIV PROTEASE INHIBITOR Filling date: 6 Sep 2025 Issue date: 5 Nov 2020 |
Application | Utility: SOLID FORMS OF A TOLL-LIKE RECEPTOR MODULATOR Filling date: 6 Sep 2025 Issue date: 5 Nov 2020 |
Application | Utility: HIV PROTEASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 5 Nov 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR IDENTIFYING AND TREATING LIVER DISEASES AND MONITORING TREATMENT OUTCOMES Filling date: 6 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: MCL-1 INHIBITORS Filling date: 6 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: ANTIBODIES SELECTIVE FOR CELLS PRESENTING EGFR AT HIGH DENSITY Filling date: 6 Sep 2025 Issue date: 15 Oct 2020 |
Grant | Utility: Therapeutic compounds Filling date: 6 Sep 2025 Issue date: 13 Oct 2020 |
Application | Utility: BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE Filling date: 6 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: FORMULATIONS OF A COMPOUND AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: THERAPEUTIC HETEROCYCLIC COMPOUNDS Filling date: 6 Sep 2025 Issue date: 8 Oct 2020 |
Grant | Utility: Compositions and methods of treating HIV Filling date: 6 Sep 2025 Issue date: 29 Sep 2020 |
Application | Utility: SOLID FORMS OF A SYK INHIBITOR Filling date: 6 Sep 2025 Issue date: 17 Sep 2020 |
Grant | Utility: FXR (NR1H4) modulating compounds Filling date: 6 Sep 2025 Issue date: 15 Sep 2020 |
Grant | Utility: PD-1/PD-L1 inhibitors Filling date: 6 Sep 2025 Issue date: 15 Sep 2020 |
Showing 150 to 200 of 302 patents.